Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Letter from Jim Otteson to the ITC Chairman from the ITC

Let me clarify. If the NDCA decision had been made prior to the ITC decision, the NDCA decision would have been controlling.

Share
New Message
Please login to post a reply